Acute lymphoid leukaemia (ALL) Gene Testing (Pilot)

This module qualitatively assesses laboratory performance in the detection of variants in acute lymphoid leukaemia.

Frequency / Number of samples

1 survey / 1 sample per survey

Tests

Molecular/Acute lymphoid leukaemia

AdenovirusQCMD Programme Code: ADVDNA18QCMD Catalogue Number: QAV054133_1 (1 Challenge)

Analysis Type: Qual & Quant.
Shipping Conditions: Dry-ice

Frequency / Number of samples

QCMD Catalogue Number: QAV054133_1
1 Challenge
8-12 Panel Members per Challenge

AdenovirusQCMD Programme Code: ADVDNA18QCMD Catalogue Number: QAV054133_2 (2 Challenges)

Analysis Type: Qual & Quant.
Shipping Conditions: Dry-ice

Frequency / Number of samples

QCMD Catalogue Number: QAV054133_2
2 Challenges
4-6 Panel Members per Challenge

Alcohol / Ammonia

Aqueous BSA – 3mL vials to assess alcohol ammonia measurements

Frequency / Number of samples

12 surveys per year / 2 samples per survey

Tests

Ethanol, Ammonia

Antenatal – Rubella serology

Clinical material (Liquid Serum / Plasma – 0.7 mL) provided to assess the detection of Rubella using serological markers

Frequency / Number of samples

4 surveys / 2 samples per survey

Tests

Rubella Total Antibody, Rubella IgG, Rubella IgM, Rubella Avidity, Rubella Interpretation

Antenatal – Syphilis serology

Clinical material provided (Liquid Serum / Plasma – 0.5 mL) to assess the detection of Syphilis using serological markers

Frequency / Number of samples

4 surveys / 2 samples per survey

Tests

Syphilis Total Antibody, Syphilis RPR, Syphilis Agglutination (TPHA/TPPA), Syphilis FTA-ab, Syphilis VDRL, Syphilis ICT, Syphilis IgG, Syphilis IgM, Syphilis Immunoblot, Syphilis Interpretation, Syphilis Total Ab EIA confirmatory

Anti-nuclear Antibodies

Serum – 500 μL provided to determine the presence of Anti-nuclear antibodies including pattern, titre and appropriate commentary.

Frequency / Number of samples

10 surveys / 2 samples per survey

Tests

Anti-Nuclear Antibodies pattern, Anti-Nuclear Antibodies titre

Anti-Saccharomyces cerevisiae Antibodies

Serum – 500 μL provided for the quantitation and qualitative assessment of Anti-Saccharomyces cerevisiae antibodies (IgG, IgA)

Frequency / Number of samples

6 surveys / 1 sample per survey

Tests

Anti-Saccharomyces cerevisiae IgA and IgG antibodies

Antiphospholipid Antibodies

Serum – 500 μL provided for quantitation and qualitative assessment of Anti-cardiolipin and Anti-Beta 2-Glycoprotein 1 antibodies (IgG, IgA and IgM)

Frequency / Number of samples

8 surveys / 1 sample per survey

Tests

Cardiolipin IgG, IgA and IgM antibodies, β2 Glycoprotein 1 IgG, IgA and IgM antibodies

Apixaban (Anti Xa)

Lyophilised plasma – 1 mL provided to assess Apixaban (Anti Xa) measurements

Frequency / Number of samples

2 surveys / 2 samples per survey

Tests

Apixaban (Anti Xa)

Arrhythmias

DNA (in TE Buffer)

Frequency / Number of samples

1 survey / 3 samples per survey

Tests

As testing approaches are still not standardized and vary between laboratories, the exact list of genes to be tested is not specified.

Aspergillus spp.QCMD Programme Code: ASPDNA18

Analysis Type: Qual
Shipping Conditions: Dry-ice

Frequency / Number of samples

QCMD Catalogue Number: QAF104140_1
1 Challenge
8-12 Panel Members per Challenge